Chemical Management, Products and Technologies

Manager’s Playbook for Getting Value from AI in the Chemicals Sector

October 14, 2022

Manager’s Playbook
Technologies like artificial intelligence (AI) and machine learning (ML) are transforming the way industries think about and consume data to drive operational efficiencies and enhance business performance. 

Spotlight

Cara Therapeutics

Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat pain, inflammation and pruritus. Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's most advanced patented compound, CR845, is currently undergoing clinical testing for acute pain and uremic pruritus. This compound possesses analgesic, anti-inflammatory and antipruritic activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.

OTHER WHITEPAPERS
news image

PROGRESS IN POLYMER SCIENCE

whitePaper | May 28, 2022

Progress in Polymer Science publishes state-of-the-art overview articles by internationally recognized authorities in polymer science and engineering, one of the fastest growing disciplines.

Read More
news image

Decarbonizing practices in the global automotive industry

whitePaper | January 27, 2023

This whitepaper examines the current state and trajectory of decarbonization within the global automotive industry. By examining and establishing a baseline on industry action, early- mid- and long-term initiatives can be highlighted to help inform manufacturers and producers how they can engage and push themselves further towards full decarbonization.

Read More
news image

Statistical Review of World Energy

whitePaper | September 16, 2021

The fall in carbon emissions from energy use was equally striking, with emissions falling by over 6% in 2020 – again, the largest decline since 1945. Although unmatched in modern peacetime.

Read More
news image

Mechanical Vapor Recompression key to steam energy upgrade within a polyolefin plant

whitePaper | September 14, 2022

Reducing energy costs and creating more sustainable local energy sources is a familiar challenge across many industries. Polyolefin process plants, for example, require a considerable amount of energy, often in the form of steam.

Read More
news image

Unlock The World’s Largest Carbon Market

whitePaper | May 14, 2022

When we tout the progress that human civilization has achieved in the past few centuries, we must recognize the costs that come with it. Among these, the cost of climate change.

Read More
news image

Hybrid Films Prepared from a Combination of Electrospinningand Casting for Offering a Dual-Phase Drug Release

whitePaper | May 24, 2022

One of the most important trends in developments in electrospinning is to combine itself with traditional materials production and transformation methods to take advantage of the unique properties of nanofibers.

Read More

Spotlight

Cara Therapeutics

Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat pain, inflammation and pruritus. Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's most advanced patented compound, CR845, is currently undergoing clinical testing for acute pain and uremic pruritus. This compound possesses analgesic, anti-inflammatory and antipruritic activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.

Events